Serum oxidized low density lipoprotein serves as a mediator for the inverse relationship between serum d-ribose and

Yanhui Lu1, Hua Jiang1, Huijing Zhang1

  • 1School of Nursing, Peking University, Beijing, China.

Insights

Elevated serum d-ribose is linked to cognitive decline in type 2 diabetes mellitus (T2DM) patients with mild cognitive impairment (MCI). Oxidized low-density lipoproteins (ox-LDL) may mediate this relationship, highlighting a potential therapeutic target.

Area of Science:

  • Endocrinology
  • Neuroscience
  • Biochemistry

Background:

  • Type 2 diabetes mellitus (T2DM) is associated with chronic hyperglycemia, inflammation, and oxidative stress, contributing to mild cognitive impairment (MCI).
  • The specific role of serum d-ribose dysregulation in T2DM-related MCI pathogenesis is not well understood.

Purpose of the Study:

  • To investigate serum d-ribose levels in T2DM patients with and without MCI compared to healthy controls.
  • To examine the association of serum d-ribose with biomarkers of ribosylation, inflammation, and oxidative stress.

Main Methods:

  • A cross-sectional study involving 89 participants (27 healthy controls, 26 T2DM normal cognition, 36 T2DM-MCI).
  • Measurements included serum d-ribose, advanced glycation end products (AGEs), receptor for advanced glycation end products (RAGE), IL-6, NF-κB, oxidized low-density lipoproteins (ox-LDL), advanced oxidation protein products (AOPP), total thiol, and non-protein thiol.
  • Cognitive function assessed using the Montreal Cognitive Assessment (MoCA).

Main Results:

  • Serum d-ribose, ox-LDL, and AOPP were significantly higher in T2DM-MCI patients compared to T2DM or controls.
  • Serum d-ribose positively correlated with AGEs, RAGE, ox-LDL, and fasting blood glucose.
  • Serum d-ribose negatively correlated with MoCA scores, with ox-LDL identified as a mediator.

Conclusions:

  • Elevated serum d-ribose is associated with mild cognitive impairment in T2DM patients.
  • Serum ox-LDL may mediate the inverse relationship between d-ribose levels and cognitive function decline in T2DM-MCI.
  • Targeting ox-LDL could be a strategy to mitigate cognitive impairment in T2DM.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
89
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
395
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
130
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K